Prospective Evaluation of Sunitinib-Induced Cardiotoxicity in Patients with Metastatic Renal Cell Carcinoma

PURPOSE: To prospectively evaluate cardiotoxicity risk with sunitinib in metastatic renal cell carcinoma (mRCC) routine clinical practice using comprehensive echocardiography and biomarker phenotyping. PATIENTS AND METHODS: In a multi-center prospective study of 90 mRCC patients, echocardiography an...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Cancer Res
Glavni autori: Narayan, Vivek, Keefe, Stephen, Haas, Naomi, Wang, Le, Puzanov, Igor, Putt, Mary, Catino, Anna, Fang, James, Agarwal, Neeraj, Hyman, David, Smith, Amanda M., Finkelman, Brian S., Narayan, Hari K., Ewer, Steven, ElAmm, Chantal, Lenihan, Daniel, Ky, Bonnie
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5516884/
https://ncbi.nlm.nih.gov/pubmed/28196874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-2869
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items